AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 3103546
Drug: Fat emulsion
RxNorm normalized name: FAT EMULSION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fat emulsion administered at a constant rate over 16 hours, starting at 1 g/kg and increasing to a maximum of 4 g/kg
Trial: 3103546
Drug: Fat emulsion
RxNorm normalized name: FAT EMULSION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fat emulsion administered at a constant rate of 4 g/kg a day over 24 hours
Trial: 31594857
Drug: High-dose vitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose vitamin D3 14,007 IU/d
Trial: 28346912
Drug: VENT (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VENT (no treatment)
Trial: 26058417
Drug: 2 L/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 L/day of water for 30 days
Trial: 23737079
Drug: CO2-laser treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CO2-laser treatment (9.6 µm, pulse-duration 20 µs, pulse-repetition-rate 20 Hz, average fluence 4.5 ± 0.5 J/cm², 20 laser pulses per spot)
Trial: 23737079
Drug: CO2-laser treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CO2-laser treatment
Trial: 21482568
Drug: Ceftaroline fosamil
RxNorm normalized name: Ceftaroline fosamil
DrugBank: Ceftaroline fosamil (DB06590)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ceftaroline fosamil (600 mg iv every 12 h)
Trial: 21482568
Drug: Ceftriaxone (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone (1 g iv every 24 h)
Trial: 15154922
Drug: Two xylitol
RxNorm normalized name: Xylitol
DrugBank: Xylitol (DB11195)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Two xylitol tablets two times a day (1.7 g xylitol d(‐1)) for 18 weeks
Trial: 15154922
Drug: Two xylitol
RxNorm normalized name: Xylitol
DrugBank: Xylitol (DB11195)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Two xylitol tablets four times per day (3.4 g xylitol d(‐1)) for 18 weeks
Trial: 15154922
Drug: No tablets
RxNorm normalized name: caffeine Oral Tablet [No Doz]
DrugBank: Nitric Oxide (DB00435)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No tablets (Control Group)
Trial: 9442992
Drug: Additional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Additional therapy (Control)
Trial: 7686799
Drug: Terfenadine (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terfenadine (120 mg/day for 3 days)
Trial: 30169600
Drug: Metformin (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (3 g/day after a dose-escalation period over 4 weeks)
Trial: 18469257
Drug: Low zinc
RxNorm normalized name: insulin low zinc
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low zinc diets (<11 mg/d) for 4-8 weeks
Trial: 31142242
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy of vitamin C, thiamine and hydrocortisone
Trial: 25311423
Drug: Dexamethasone (short-term,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (short-term, high-dose, perioperative use)
Trial: 21849187
Drug: Acute androgen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acute androgen suppression therapy
Trial: 21849187
Drug: Chronic androgen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chronic androgen suppression therapy
Trial: 11441324
Drug: Zinc lozenges
RxNorm normalized name: Zinc Lozenges
DrugBank: Zinc gluconate (DB11248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zinc lozenges (four to six lozenges/day for 10 days)
Trial: 2291748
Drug: Standardized garlic-powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standardized garlic-powder tablets (800 mg daily for 16 weeks)
Trial: 2291748
Drug: Placebo tablets
RxNorm normalized name: placebo Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo tablets (same number as garlic tablets for 16 weeks)
Trial: 28865799
Drug: Tedizolid phosphate
RxNorm normalized name: Tedizolid Phosphate
DrugBank: Tedizolid (DB14569)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Tedizolid phosphate 400 mg PO
Trial: 28865799
Drug: Tedizolid phosphate
RxNorm normalized name: Tedizolid Phosphate
DrugBank: Tedizolid (DB14569)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Tedizolid phosphate 600 mg PO
Trial: 28865799
Drug: Tedizolid phosphate
RxNorm normalized name: Tedizolid Phosphate
DrugBank: Tedizolid (DB14569)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Tedizolid phosphate (all doses)
Trial: 20979461
Drug: E2+DRSP (17β‐estradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E2+DRSP (17β‐estradiol 1 mg/day plus drospirenone 2 mg/day)
Trial: 15019795
Drug: Fluoxetine (sub-analysis)
DrugBank: Fluoxetine (DB00472)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluoxetine (sub-analysis)
Trial: 8001289
Drug: Monoclonal antibody-based
RxNorm normalized name: SARS-CoV-2 antibody-based IVIG
DrugBank: Anti-SARS-CoV-2 immunoglobulin (DB16360)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monoclonal antibody-based enzyme immunoassay (EIA) for urinary 18-hydroxycortisol
Trial: 3078281
Drug: Oral trifluoperazine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral trifluoperazine (TFP) 7 mg
Trial: 3078281
Drug: Inhaled trifluoperazine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled trifluoperazine (TFP) 10 mg/ml, nebulized for 5 min
Trial: 3078281
Drug: Saline (control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline (control for inhaled TFP)
Trial: 28262330
Drug: Paracetamol prophylaxis
RxNorm normalized name: STONE PROPHYLAXIS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol prophylaxis
Trial: 19142041
Drug: Sham kinesiology
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham kinesiology treatment (administered weekly for 5 weeks)
Trial: 19142041
Drug: Real kinesiology
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Real kinesiology treatment (4 sessions)
Trial: 19142041
Drug: Sham kinesiology
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham kinesiology treatment (4 sessions)
Trial: 16324923
Drug: glyburide (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: glyburide (10 mg)
Trial: 16324923
Drug: glimepiride (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: glimepiride (4 mg)
Trial: 11081528
Drug: Inhaled nitric
RxNorm normalized name: nitric oxide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nitric oxide (n=63)
Trial: 8885811
Drug: Specific IgE
RxNorm normalized name: BSA specific IgE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific IgE antibodies to food allergens (egg white, fish, wheat, peanut, soy, milk)
Trial: 8885811
Drug: Specific IgE
RxNorm normalized name: BSA specific IgE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific IgE antibodies to food allergens
Trial: 1525984
Drug: Tablets containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablets containing 90% USRDA of Mg
Trial: 1525984
Drug: Tablets containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablets containing 180% USRDA of Mg
Trial: 4091884
Drug: Ticlopidine treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticlopidine treatment (500 mg/day) for 30 days
Trial: 30682576
Drug: Mindset that
RxNorm normalized name: acetaminophen
DrugBank: Acetaminophen (DB00316)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mindset that non-life-threatening symptoms are unfortunate side effects of treatment
Trial: 25270426
Drug: U.S. Food
FDA approved: no
EMA approved: no
PMDA approved: no
Description: U.S. Food and Drug Administration recommended pharmacologic treatments (RPT)
Trial: 22828681
Drug: Caudal epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caudal epidural injections of 0.5% lidocaine mixed with 1 mL of steroid
Trial: 17440642
Drug: Broad-spectrum immune
RxNorm normalized name: Immune Globulin
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Broad-spectrum immune modulatory therapy
Trial: 15116072
Drug: Moderately high
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderately high intake of zinc (811 micromol/day; 53 mg/day)
Trial: 15116072
Drug: Low dietary
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dietary zinc (45.9 micromol/day; 3 mg/day)
Trial: 15116072
Drug: High dietary
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dietary zinc (811 micromol/day; 53 mg/day)
Trial: 8088198
Drug: Epidural morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural morphine (C)
Trial: 2733993
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose oral colchicine (1.2 mg/day)
Trial: 2733993
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C (250 mg/day orally)
Trial: 31660788
Drug: General Anaesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General Anaesthesia (GA) with tumescent anaesthesia (G + T)
Trial: 24021298
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (stable dosage of dopaminomimetic drugs only)
Trial: 21294931
Drug: Vitamin A
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin A supplementation (VAS) 50,000 IU (15 mg) at birth
Trial: 14675268
Drug: Rabeprazole 20
RxNorm normalized name: RABEprazole 20 mg oral delayed release tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole 20 mg once a morning
Trial: 14675268
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg once a morning
Trial: 14675268
Drug: Lansoprazole 30
RxNorm normalized name: lansoprazole 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole 30 mg once a morning
Trial: 3157709
Drug: 2% erythromycin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% erythromycin ointment
Trial: 27106640
Drug: 24-hour antibiotic
RxNorm normalized name: Antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24-hour antibiotic group
Trial: 27106640
Drug: Extended antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended antibiotic group
Trial: 24806263
Drug: Zaleplon (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zaleplon (10 mg/day)
Trial: 18403946
Drug: Ginger (1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginger (1200 mg)
Trial: 10634827
Drug: simvastatin +
RxNorm normalized name: Simvastatin
DrugBank: Simvastatin (DB00641)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: simvastatin + omega-3 fatty acids at 3.36 g/d
Trial: 8939178
Drug: Nedocromil sodium
RxNorm normalized name: Nedocromil Sodium
DrugBank: Nedocromil (DB00716)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nedocromil sodium 4 mg four times daily for 12 weeks
Trial: 8939178
Drug: Albuterol 0.2
RxNorm normalized name: albuterol 0.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol 0.2 mg four times daily for 12 weeks
Trial: 1382927
Drug: Hemodilution therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hemodilution therapy (by rapid venesection, venous infusion of autologous plasma and 500 ml dextran 40)
Trial: 1382927
Drug: Hemodilution therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hemodilution therapy and Standard therapy
Trial: 31272313
Drug: Moderate number
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate number of ARV drug changes (up to 2 per 6 months)
Trial: 26473333
Drug: High-dose TwHF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose TwHF (2.0 mg·kg·d)
Trial: 26473333
Drug: Low-dose TwHF
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose TwHF (1.5 mg·kg·d)
Trial: 26473333
Drug: Mesalazine (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mesalazine (3 g/d)
Trial: 21586714
Drug: Vitamin A
RxNorm normalized name: Vitamin A
DrugBank: Vitamin A (DB00162)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin A supplementation (7000 μg of retinol equivalents as retinyl palmitate)
Trial: 21586714
Drug: Beta carotene
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta carotene supplementation (42 mg of all-trans beta carotene)
Trial: 14688378
Drug: CML66-L peptide
RxNorm normalized name: PEPTIDE-T
DrugBank: Peptide-T (DB19279)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CML66-L peptide
Trial: 14688378
Drug: CML66-L
RxNorm normalized name: L
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CML66-L
Trial: 8160279
Drug: IgM-enriched immunoglobulin
RxNorm normalized name: IgM-enriched immunoglobulins
DrugBank: Pentaglobin (DB15865)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IgM-enriched immunoglobulin (5 ml/kg/d for three days)
Trial: 8160279
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (standard treatment with antibiotics and fresh plasma/whole blood transfusions)
Trial: 29488676
Drug: Insulin alone
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin alone or in combination with oral hypoglycaemic drugs; prescribed to 24.4% to 34.5% of patients with diabetes.
Trial: 29488676
Drug: Insulin prescription
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin prescription in the administrative registry.
Trial: 24708643
Drug: Semi-standardised acupuncture
RxNorm normalized name: Semi-Daonil
DrugBank: Glyburide (DB01016)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Semi-standardised acupuncture plus rescue medication (cetirizine)
Trial: 24708643
Drug: Sham acupuncture
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham acupuncture plus rescue medication (cetirizine)
Trial: 24708643
Drug: Rescue medication
RxNorm normalized name: ALLERGENIC EXTRACT, MEADOW FESCUE POLLEN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rescue medication (cetirizine) alone
Trial: 23046781
Drug: Cognitive Processing
RxNorm normalized name: Allogeneic processed thymus tissue
DrugBank: Allogeneic processed thymus tissue (DB16736)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Processing Therapy (CPT) with written accounts (WA) component
Trial: 24509894
Drug: Oxytocin nasal
RxNorm normalized name: oxytocin Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxytocin nasal spray (80 IU a day)
Trial: 22216936
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (Project Toward No Drug Abuse)
Trial: 15345791
Drug: Hormone therapy
RxNorm normalized name: INVESTIGATIONAL HORMONE THERAPY/REPLACEMENT,OTHER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hormone therapy (estrogen)
Trial: 15345791
Drug: Reinstitution of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reinstitution of estrogen or initiation/increase in antidepressant dose
Trial: 15345791
Drug: Discontinuation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinuation of hormone therapy
Trial: 15345791
Drug: Hormone therapy
RxNorm normalized name: INVESTIGATIONAL HORMONE THERAPY/REPLACEMENT,OTHER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hormone therapy (estrogen) or selective estrogen receptor modulator
Trial: 10439645
Drug: Thiopental 5
RxNorm normalized name: thiopental 5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopental 5 mg·kg‐1
Trial: 10439645
Drug: Etomidate 0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etomidate 0.3 mg·kg‐1
Trial: 7598439
Drug: WHO/UNICEF oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WHO/UNICEF oral rehydration solution (ORS)
Trial: 7598439
Drug: Fermented maize
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fermented maize solution
Trial: 7598439
Drug: Unfermented maize
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unfermented maize solution
Trial: 28824012
Drug: 3.0 g
RxNorm normalized name: LACTIC ACID 23.0 g in 1 L TOPICAL SOLUTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.0 g of CLA daily for 3 months
Trial: 28824012
Drug: Sunflower oil
RxNorm normalized name: Sunflower Oil
DrugBank: Sunflower oil (DB14329)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sunflower oil as placebo daily for 3 months
Trial: 19058760
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment (Labetalol and Lisinopril combined)
Trial: 7741285
Drug: Thiobarbiturate (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiobarbiturate (5 mg/kg thiopental or thiamylal)
Trial: 7741285
Drug: Oxybarbiturate (1.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxybarbiturate (1.75 mg/kg methohexital)
Trial: 7741285
Drug: Thiobarbiturate (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiobarbiturate (5 mg/kg)
Trial: 2201652
Drug: Acetyl-L-carnitine (LAC)
RxNorm normalized name: acetyl-L-carnitine
DrugBank: Acetylcarnitine (DB08842)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetyl-L-carnitine (LAC) 2 g/day
Trial: 6259941
Drug: Ointment containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ointment containing polymyxin, neomycin and bacitracin (PNB)
Trial: 6259941
Drug: Iodophor ointment
RxNorm normalized name: iodophors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iodophor ointment (PI2)
Trial: 6259941
Drug: No topical
RxNorm normalized name: Altreno Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No topical agent (Control)
Trial: 27845030
Drug: Ultrasound-guided capsule-preserved
RxNorm normalized name: Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound-guided capsule-preserved hydrodilatation with corticosteroid (1mL of 40mg/mL triamcinolone acetonide, 6mL of 1% lidocaine, and normative saline)
Trial: 27845030
Drug: Ultrasound-guided IACI
RxNorm normalized name: Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound-guided IACI alone (1mL of 40mg/mL triamcinolone acetonide and 3mL of 1% lidocaine)
Trial: 26353875
Drug: Intranasal 2%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal 2% mupirocin plus topical antisepsis with chlorhexidine gluconate for 5 days
Trial: 26353875
Drug: Placebo ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo ointment and placebo cloths for skin antisepsis for 5 days
Trial: 21890077
Drug: Drug-eluting stents
RxNorm normalized name: Fraxinus velutina pollen
DrugBank: Fraxinus velutina pollen (DB10455)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-eluting stents (DESs) in patients with normal GFR (≥60 ml/min/1.73 m²)
Trial: 21890077
Drug: Drug-eluting stents
RxNorm normalized name: Fraxinus velutina pollen
DrugBank: Fraxinus velutina pollen (DB10455)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-eluting stents (DESs) in patients with low GFR (<60 ml/min/1.73 m²)
Trial: 21890077
Drug: Bare-metal stents
RxNorm normalized name: menthone 1,2-glycerol ketal, (-)-
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bare-metal stents in patients with low GFR (<60 ml/min/1.73 m²)
Trial: 21890077
Drug: Bare-metal stents
RxNorm normalized name: menthone 1,2-glycerol ketal, (-)-
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bare-metal stents in patients with normal GFR (≥60 ml/min/1.73 m²)
Trial: 15328386
Drug: VML 588
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VML 588 (0.05, 0.20 and 0.40 mg/kg/h)
Trial: 11418315
Drug: 90Y Zevalin
RxNorm normalized name: Zevalin KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 90Y Zevalin (0.4 mCi/kg therapeutic dose after 5 mCi tracer dose)
Trial: 11418315
Drug: Rituximab (375
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rituximab (375 mg/m2 weekly x 4)
Trial: 29728552
Drug: No laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No laser therapy (Control)
Trial: 24740207
Drug: rs705117 SNP
RxNorm normalized name: SNP-ACTH (1-39)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rs705117 SNP (G allele)
Trial: 21388079
Drug: Hydroxyzine 75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxyzine 75 mg
Trial: 10913225
Drug: Arachidonic acid
RxNorm normalized name: Arachidonic acid
DrugBank: Arachidonic Acid (DB04557)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arachidonic acid (AA) 300 mg
Trial: 10913225
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of AA (300 mg), EPA (110 mg), and DHA (400 mg)
Trial: 1526683
Drug: Cefodizime (CDZ)
RxNorm normalized name: cefodizime
DrugBank: Cefodizime (DB13470)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefodizime (CDZ) 2 g i.v. once daily for seven days